Sign In
Buy CNTA
$40.50
+0 (+0%)
At Close: Jul 23, 2026
Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital
08:00am, Monday, 04'th Oct 2021
~ New $300 million facility, combined with Company's cash balance as of June 30, 2021, provides access to over $900 million to advance development programs and enable pursuit of strategic business dev
Here's why Centessa Pharma is up 20% on Thursday morning
03:06pm, Thursday, 09'th Sep 2021
Centessa Pharmaceuticals PLC – ADR (NASDAQ: CNTA), in partnership with its subsidiary ApcinteX Limited announced that results from its ongoing first-in-human proof-of-concept study to analyze Serpin
~ 88% reduction in median Annualized Bleeding Rate (ABR) for all bleeds and 94% reduction in median ABR for spontaneous joint bleeds in highest dose tested ~
Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
04:15pm, Wednesday, 01'st Sep 2021
CAMBRIDGE, Mass. & LONDON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate in a
Centessa Hits the Market in 3rd Biggest Biotech IPO of the Year
09:53am, Tuesday, 08'th Jun 2021
If two heads are better than one, consider what 10 can accomplish. That's the thinking behind Centessa Pharmaceuticals ( CNTA , Financial), a company constructed from the merger of 10 small drug compa
Centessa Hits the Market in Third Biggest Biotech IPO of the Year
09:52am, Tuesday, 08'th Jun 2021
If two heads are better than one, consider what ten can accomplish.
Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
04:15pm, Monday, 07'th Jun 2021
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate in
Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs
04:15pm, Friday, 04'th Jun 2021
CAMBRIDGE, Mass. and LONDON, June 04, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Centessa”), a clinical-stage company employing its innovative asset-centric business model to discove
U.S. IPO Weekly Recap And Week Ahead
11:23pm, Saturday, 29'th May 2021
U.S. IPO Weekly Recap And Week Ahead
Centessa Announces Pricing of Initial Public Offering
10:49pm, Thursday, 27'th May 2021
CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--Centessa Announces Pricing of Initial Public Offering
